Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study
| Autor: | Ilaria Del Giudice, Livio Trentin, Valentina Arena, Monia Marchetti, Caterina Ilari, Rocio Edith García-Jacobo, Gian Matteo Rigolin, Aurora Melandri, Luciana Cafforio, Robin Foà, Gianluigi Reda, Francesca Romana Mauro, Alfonso Piciocchi, Francesca Cura, Francesco Albano, Sara Raponi, Stefano Molica, Paola Mariglia, Anna Guarini, Antonio Cuneo, Maria Antonella Bardi, Mauro Nanni, Nadia Peragine, Marco Vignetti, Paolo Sportoletti |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Oncology
medicine.medical_specialty business.industry Immunology Phases of clinical research Cell Biology Hematology Biochemistry NO chemistry.chemical_compound COMPLEX KARYOTYPE chemistry Internal medicine Ibrutinib Complex Karyotype Medicine Rituximab RITUXIMAB IBRUTINIB business UNFIT PATIENTS COMPLEX KARYOTYPE UNFIT PATIENTS CLL IBRUTINIB RITUXIMAB CLL medicine.drug |
| Zdroj: | Blood. 138:2727-2730 |
| ISSN: | 1528-0020 0006-4971 |
| DOI: | 10.1182/blood.2021011883 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|